Advent Life Sciences led a $80m Series C round in Proximie.

Advent Life Sciences, a venture and growth capital firm, led a $80m Series C round in Proximie, a health technology platform, with participation from Emerson Collective, SoftBank Vision Fund 2, British Patient Capital, Mubadala and the Minderoo Foundation. "Our vision is to democratize surgery through better data by connecting every OR and Cath Lab in the world. We began this journey enabling surgeons to virtually join any OR. Now, we're using this capability to digitize the operating room, bringing patients the collective expertise of the best surgeons in the world - where data collected and shared on Proximie can help them receive life-saving care, no matter where they live," Nadine Hachach-Haram, Proximie CEO and Founder.